Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2018, Article ID 8271313, 7 pages
https://doi.org/10.1155/2018/8271313
Research Article

Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma

1Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China
2Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China

Correspondence should be addressed to Yue Chen; moc.621@3255euynehc

Received 3 April 2018; Accepted 9 August 2018; Published 5 September 2018

Academic Editor: Pietro Muto

Copyright © 2018 Yin Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Chiesa and F. De Paoli, “Distant metastases from nasopharyngeal cancer,” ORL, vol. 63, no. 4, pp. 214–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Y. Yang, Y. Zhang, W. Shi et al., “Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?” Annals of Nuclear Medicine, vol. 28, no. 5, pp. 411–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. C. Lau, “The utility of 18F-Fluoride PET/CT for the detection of skull base involvement in nasopharyngeal carcinoma,” SNM Annual Meeting Abstracts, vol. 51, p. 460, 2010. View at Google Scholar
  5. L. Zhang, L. Chen, Q. Xie et al., “A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and 99mTc-MDP whole-body bone scanning for imaging osteolytic bone metastases,” BMC Medical Imaging, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Czernin, W. A. Weber, and H. R. Herschman, “Molecular imaging in the development of cancer therapeutics,” Annual Review of Medicine, vol. 57, no. 1, pp. 99–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. P. L. Jager, M. A. de Korte, M. N. Lub-de Hooge et al., “Molecular imaging: what can be used today,” Cancer Imaging, vol. 5, pp. S27–S32, 2005. View at Publisher · View at Google Scholar
  8. G. Segall, D. Delbeke, M. G. Stabin et al., “SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0,” Journal of Nuclear Medicine, vol. 51, no. 11, pp. 1813–1820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Simoncic, S. Perlman, G. Liu et al., “Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases,” Clinical Genitourinary Cancer, vol. 13, no. 1, pp. e7–e17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. N. A. Damle, C. Bal, G. P. Bandopadhyaya et al., “The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan,” Japanese Journal of Radiology, vol. 31, no. 4, pp. 262–269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Boellaard, M. J. O’Doherty, A. Chiti, and B. J. Krause, “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 7, pp. 1432-1433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Delbeke, R. E. Coleman, M. J. Guiberteau et al., “Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 885–895, 2006. View at Google Scholar
  13. J. D. Oldan, A. S. Hawkins, and B. B. Chin, “18F sodium fluoride PET/CT in patients with prostate cancer: quantification of normal tissues, benign degenerative lesions, and malignant lesions,” World Journal of Nuclear Medicine, vol. 15, no. 2, pp. 102–108, 2016. View at Publisher · View at Google Scholar
  14. L. A. Wu, H. M. Liu, C. W. Wang, Y. F. Chen, R. L. Hong, and J. Y. Ko, “Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: differentiation from recurrent or metastatic disease with MR imaging,” Radiology, vol. 264, no. 1, pp. 136–145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Beheshti, A. Rezaee, H. Geinitz, W. Loidl, C. Pirich, and W. Langsteger, “Evaluation of prostate cancer bone metastases with 18F-NaF and 18F-fluorocholine PET/CT,” Journal of Nuclear Medicine, vol. 57, no. S3, pp. 55S–60S, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Löfgren, J. Mortensen, S. H. Rasmussen et al., “A prospective study comparing 99mTc-hydroxyethylene-diphosphonate planar bone scintigraphy and whole-body SPECT/CT with 18F-fluoride PET/CT and 18F-fluoride PET/MRI for diagnosing bone metastases,” Journal of Nuclear Medicine, vol. 58, no. 11, pp. 1778–1785, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Huang and X. Ouyang, “Biochemical-markers for the diagnosis of bone metastasis: a clinical review,” Cancer Epidemiology, vol. 36, no. 1, pp. 94–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wang, Z. Xu, M. Ma, N. Wang, and K. Wang, “Network analysis of microRNAs, transcription factors, target genes and host genes in nasopharyngeal carcinoma,” Oncology Letters, vol. 11, no. 6, pp. 3821–3828, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. K. T. Lee, J. K. Tan, A. K. Lam, and S. Y. Gan, “MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: a critical review,” Critical Reviews in Oncology/Hematology, vol. 103, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. H. B. Wu, Q.-S. Wang, M.-F. Wang, X. Zhen, W.-L. Zhou, and H.-S. Li, “Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT,” Journal of Nuclear Medicine, vol. 52, no. 3, pp. 341–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Qin, F. Hu, M. M. R. Arnous, and X. Lan, “Detection of non-FDG-avid residual sinonasal malignant melanoma in the skull base with 11C-choline PET and contrast-enhanced MRI,” Clinical Nuclear Medicine, vol. 42, no. 11, pp. 885-886, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Le, Y. Chen, F. Zhou, G. Liu, Z. Huang, and Y. Chen, “Comparative diagnostic value of 18F-fluoride PET-CT versus MRI for skull-base bone invasion in nasopharyngeal carcinoma,” Nuclear Medicine Communications, vol. 37, no. 10, pp. 1062–1068, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Y. Liu, C.-Y. Lin, J. T. Chang et al., “18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma,” Journal of Nuclear Medicine, vol. 48, no. 10, pp. 1614–1619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bastawrous, P. Bhargava, F. Behnia, D. S. Djang, and D. R. Haseley, “Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice,” Radiographics, vol. 34, no. 5, pp. 1295–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. T. Shen, Z. L. Qiu, T. T. Han, and Q. Y. Luo, “Performance of 18F-fluoride PET or PET/CT for the detection of bone metastases: a meta-analysis,” Clinical Nuclear Medicine, vol. 40, no. 2, pp. 103–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. C. G. Mick, T. James, J. D. Hill, P. Williams, and M. Perry, “Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease,” American Journal of Roentgenology, vol. 203, no. 2, pp. 263–271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Iagaru, E. Mittra, C. Mosci et al., “Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial,” Journal of Nuclear Medicine, vol. 54, no. 2, pp. 176–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Scimeca, N. Urbano, R. Bonfiglio, O. Schillaci, and E. Bonanno, “Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork,” Future Oncology, vol. 14, no. 11, pp. 1013–1015, 2018. View at Publisher · View at Google Scholar